Quarterly report · Q2
3540.TEDINET S100RNLL
Period2023-01-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥42.9bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.8bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥2.3bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.9bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.3bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.2bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.5bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.2bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥37.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥30.2bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥18.6bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥11.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥18.3bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥17.2bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥542m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥861m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥454m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥257m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.7bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.7bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥122.63 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.53 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.16 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152.85 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.94 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 50.8% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 441
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from redemption of investment securities inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from redemption of investment securities inv cf | CurrentYTDDuration | 100000000 | JPY |
| Other net inv cf | Prior1YTDDuration | 1000000 | JPY |
| Other net inv cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -4074000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -454000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | 2000000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | － | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -282000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -252000000 | JPY |
| Other net fin cf | Prior1YTDDuration | － | JPY |
| Other net fin cf | CurrentYTDDuration | -5000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | 1717000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -257000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 2000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 28000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -1492000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -142000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 3649000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1731000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1YTDDuration | － | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYTDDuration | 17000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 2157000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 1606000000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 678000000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 745000000 | JPY |
| P personnel expenses warehouse deposit expenses | Prior1YTDDuration | 368000000 | JPY |
| P personnel expenses warehouse deposit expenses | CurrentYTDDuration | 401000000 | JPY |
| Packing freightage and delivery expense | Prior1YTDDuration | 1067000000 | JPY |
| Packing freightage and delivery expense | CurrentYTDDuration | 1072000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -0 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -6000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 18000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 29000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)北陸財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-08-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第24期第２四半期（自 2023年４月１日 至 2023年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社歯愛メディカル | |
| Company name in english cover page | FilingDateInstant | C.I. MEDICAL CO.,LTD. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 清水 清人 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)石川県白山市鹿島町一号９番地１ | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)076-278-8802（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役経営管理部長 三好 誠治 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)石川県白山市旭丘二丁目６番地 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)076-278-8802（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役経営管理部長 三好 誠治 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E32453 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |